Integral Molecular News

Potent and Efficacious Inhibition of CXCR2 Signaling by Biparatopic Nanobodies Combining Two Distinct Modes of Action

BRADLEY ET AL. 2015. MOL PHARMACOL (87):251–262.

Read More

Upcoming Events

Immuno-Oncology Summit
Aug 7th-9th, 2024
Philadelphia, PA
 
Discovery on Target
Sep 30th-Oct 3rd, 2024
Boston, MA
 
World Vaccine Congress Europe
Oct 29th-31st, 2024
Barcelona, Spain